The DNA methylation inhibitor 5-azacytidine induces autoreactivity in cloned CD4+ T cells, but the functional consequences of this response are unknown. We now report that CD4+ T cells treated with 5-azacytidine respond to autologous antigen-presenting cells and induce autologous B cell differentiation without exogenous antigen or mitogen. This mechanism could play a role in some autoimmune diseases characterized by T cell DNA hypomethylation and polyclonal B cell activation.
|Original language||English (US)|
|Number of pages||14|
|Journal||Clinical Immunology and Immunopathology|
|State||Published - Jun 1990|
ASJC Scopus subject areas
- Immunology and Allergy
- Pathology and Forensic Medicine